Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

J D Leander

Showing results (141-150 of 155) with videos related to

Pageof 16
Sort By:
Drug and Alcohol Dependence|February 1, 1985
PicenadolD M Zimmerman, S E Smits, M D Hynes, et al.
Journal of Medicinal Chemistry|December 8, 1995
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonistP L Ornstein, M B Arnold, N K Allen, et al.
Journal of Medicinal Chemistry|August 21, 1992
NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomerP L Ornstein, D D Schoepp, M B Arnold, et al.
Progress in Clinical and Biological Research|January 1, 1990
5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethersH Schmidhammer, J D Leander, K Mayer-Valkanover, et al.
Journal of Medicinal Chemistry|April 1, 1991
Synthesis and pharmacological evaluation of a major metabolite of ameltolide, a potent anticonvulsantD W Robertson, E E Beedle, J H Krushinski, et al.
Environmental Research|August 1, 1982
Morphological, pharmacokinetic, and hematological studies of lead-exposed pigeonsE Anders, D D Dietz, C R Bagnell, et al.
Journal of Medicinal Chemistry|March 1, 1988
Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolinesD M Zimmerman, B E Cantrell, J K Swartzendruber, et al.
Journal of Medicinal Chemistry|October 1, 1993
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptorsD M Zimmerman, J D Leander, B E Cantrell, et al.
Neuropharmacology|September 1, 1995
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acidD D Schoepp, D Lodge, D Bleakman, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitutionP L Ornstein, M B Arnold, N K Allen, et al.
Pageof 16

Showing results (141-150 of 155) with videos related to

Sort By:
Pageof 16
Drug and Alcohol Dependence|February 1, 1985
PicenadolD M Zimmerman, S E Smits, M D Hynes, et al.
Journal of Medicinal Chemistry|December 8, 1995
(3SR,4aRS,6SR,8aRS)-6-(1H-tetrazol-5-yl)decahydroisoquinoline-3-carboxylic acid, a novel, competitive, systemically active NMDA and AMPA receptor antagonistP L Ornstein, M B Arnold, N K Allen, et al.
Journal of Medicinal Chemistry|August 21, 1992
NMDA antagonist activity of (+/-)-(2SR,4RS)-4-(1H-tetrazol-5-ylmethyl)piperidine-2-carboxylic acid resides with the (-)-2R,4S-isomerP L Ornstein, D D Schoepp, M B Arnold, et al.
Progress in Clinical and Biological Research|January 1, 1990
5-Methylated naloxone, naltrexone, oxymorphone, and their 14-O-methyl ethersH Schmidhammer, J D Leander, K Mayer-Valkanover, et al.
Journal of Medicinal Chemistry|April 1, 1991
Synthesis and pharmacological evaluation of a major metabolite of ameltolide, a potent anticonvulsantD W Robertson, E E Beedle, J H Krushinski, et al.
Environmental Research|August 1, 1982
Morphological, pharmacokinetic, and hematological studies of lead-exposed pigeonsE Anders, D D Dietz, C R Bagnell, et al.
Journal of Medicinal Chemistry|March 1, 1988
Synthesis and analgesic properties of N-substituted trans-4a-aryldecahydroisoquinolinesD M Zimmerman, B E Cantrell, J K Swartzendruber, et al.
Journal of Medicinal Chemistry|October 1, 1993
Structure-activity relationships of trans-3,4-dimethyl-4-(3-hydroxyphenyl)piperidine antagonists for mu- and kappa-opioid receptorsD M Zimmerman, J D Leander, B E Cantrell, et al.
Neuropharmacology|September 1, 1995
In vitro and in vivo antagonism of AMPA receptor activation by (3S, 4aR, 6R, 8aR)-6-[2-(1(2)H-tetrazole-5-yl) ethyl] decahydroisoquinoline-3-carboxylic acidD D Schoepp, D Lodge, D Bleakman, et al.
Journal of Medicinal Chemistry|May 24, 1996
Structure-activity studies of 6-(tetrazolylalkyl)-substituted decahydroisoquinoline-3-carboxylic acid AMPA receptor antagonists. 1. Effects of stereochemistry, chain length, and chain substitutionP L Ornstein, M B Arnold, N K Allen, et al.
Pageof 16